A Rational Framework for the Development, Evaluation, and Use of Psychoactive Drugs
- 1 February 1968
- journal article
- review article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 124 (8S), 1-19
- https://doi.org/10.1176/ajp.124.8s.1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Considerations for the pre-clinical evaluation of new psychiatric drugs: A case study with phenothiazine-like tranquilizersPsychopharmacology, 1966
- The effects of chlorpromazine and pentobarbital on sustained attention in the ratPsychopharmacology, 1965
- On the dissimilar effects of drugs on the digit symbol substitution and continuous performance testsPsychopharmacology, 1964
- The effects of chlordiazepoxide and chlorpromazine on a punishment discriminationPsychopharmacology, 1962
- Complications Associated with Lysergic Acid Diethylamide (LSD-25)Published by American Medical Association (AMA) ,1962
- The Testing of New Drugs and Other Therapeutic AgentsJAMA, 1961
- The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the ratPsychopharmacology, 1960
- AMPHETAMINE SULFATE AND ATHLETIC PERFORMANCEJAMA, 1959
- Stimulus change, reactions to novelty, and response decrement.Psychological Review, 1959
- The effect of drugs on arousal responses produced by electrical stimulation of the reticular formation of the brainElectroencephalography and Clinical Neurophysiology, 1958